Committee/Subcommittee: | Activity: | |
House Energy and Commerce | Referral | |
Subcommittee on Health | Referral | |
House Ways and Means | Referral | |
Subcommittee on Health | Referral |
***NONE***
***NONE***
Rep Davis, Danny K. - 5/23/2002 [IL-7] | Rep Emerson, Jo Ann - 4/4/2001 [MO-8] |
Rep Frank, Barney - 4/4/2001 [MA-4] | Rep Gilchrest, Wayne T. - 4/4/2001 [MD-1] |
Rep Gutknecht, Gil - 4/4/2001 [MN-1] | Rep Horn, Stephen - 4/4/2001 [CA-38] |
Rep Johnson, Timothy V. - 4/4/2001 [IL-15] | Rep Jones, Walter B., Jr. - 4/4/2001 [NC-3] |
Rep Leach, James A. - 4/4/2001 [IA-1] | Rep Sanders, Bernard - 4/4/2001 [VT] |
Rep Terry, Lee - 4/4/2001 [NE-2] | Rep Traficant, James A., Jr. - 4/4/2001 [OH-17] |
Rep Wynn, Albert Russell - 4/4/2001 [MD-4] |
Drug Availability and Health Care Access Improvement Act of 2001 - Amends title XIX (Medicaid) of the Social Security Act (SSA) to require State Medicaid plans to cover prescribed drugs for qualified Medicare (SSA title XVIII) and other low-income Medicare beneficiaries.
Provides full Federal funding for such Medicaid coverage.
Amends SSA title XVIII part C (Medicare+Choice), as amended by the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000, with respect to access to Medicare+Choice plans through an increase in the minimum Medicare+Choice capitation rate.
Amends the Federal Food, Drug, and Cosmetic Act with respect to the program for importation of certain prescription drugs by pharmacists and wholesalers to: (1) revise importer drug testing requirements; (2) prohibit drug manufacturers from discriminating against U.S. pharmacists, wholesalers, or consumers; and (3) changes from the Secretary of Health and Human Services to the Comptroller General responsibility for a specified study on drug imports.